Dr Reddy’s Stock Tanks 7% Post-Q3 Earnings

New Delhi: Shares of Dr Reddy’s Laboratories on Friday declined nearly seven per cent after the company’s third quarter earnings failed to cheer investors. The stock dropped 6.65 per cent to Rs1,203.60 on the BSE. At the NSE, it tanked 6.66 per cent to Rs1,203.50. Dr Reddy’s Labora-tories on Thursday said its consolidated net profit increased 2 per cent to Rs1,413 crore in the third quarter ended December 31, 2024. The Hyderabad-based drug major had reported a profit of Rs1,379 crore for the October-December period of last fiscal. Revenue increased to Rs8,359 crore from Rs7,215 crore a year ago, Dr Reddys Laboratories said in a statement.